logo

For the Inventor, By the Inventor

Suita, Japan

Masatsugu Hori

This inventor holds 6 USPTO granted patents. Top assignees: Riken Corporation, Daiichi Sankyo Company, Limited, National Cerebral and Cardiovascular Center. Active years: 2010-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masatsugu Hori. Retrieved from https://idiyas.com/inventor/masatsugu-hori

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 6

% Patents Active = 16.7

Average Co-Inventor Count = 5.9

ph-index = 1


Location History:

  • Hyogo, JP (2012)
  • Osaka, JP (2013)
  • Suita, JP (2010 - 2015)

Company Filing History:

goldMedal5 out of 892 
 
Riken Corporation
 patents
silverMedal1 out of 463 
 
Daiichi Sankyo Company, Limited
 patents
bronzeMedal1 out of 51 
 
National Cerebral and Cardiovascular Center
 patents
4. 1 out of 1,045 
 
Osaka University
 patents
where one patent can have more than one assignee

Years Active: 2010-2015

Loading Chart...
6 patents (USPTO):Explore Patents
1. 9095600 - Prophylactic and/or therapeutic agent for cardiac infarction (2015-08-04),
2. 8518644 - Method of judging inflammatory disease by using single nucleotide polymorphism (2013-08-27),
3. 8158351 - Method for determining inflammatory disease (2012-04-17),
4. 8048625 - Method of examining inflammatory disease and method of screening remedy for inflammatory disease (2011-11-01),
5. 8026063 - Method of examining inflammatory disease and method of screening remedy for imflammatory disease (2011-09-27),
6. 7754422 - Method of judging inflammatory disease (2010-07-13),

Title: Masatsugu Hori: Innovator in Cardiac Therapeutics

Introduction

Masatsugu Hori is a prominent inventor based in Suita, Japan. He has made significant contributions to the field of cardiac therapeutics, holding a total of 6 patents. His work focuses on developing innovative solutions for myocardial infarction and inflammatory diseases.

Latest Patents

Hori's latest patents include a novel prophylactic and therapeutic agent for cardiac infarction. This invention relates to a drug that provides prevention and treatment for myocardial infarction or myocardial ischemia-reperfusion injury, utilizing a lipid membrane structure that retains adenosine. Another significant patent involves a method for judging inflammatory diseases by using single nucleotide polymorphism (SNP). This method aims to identify genetic polymorphisms associated with the onset and progression of inflammatory diseases, including myocardial infarction.

Career Highlights

Throughout his career, Masatsugu Hori has worked with esteemed organizations such as Riken Corporation and Osaka University. His research and innovations have had a profound impact on the medical community, particularly in the area of cardiac health.

Collaborations

Hori has collaborated with notable colleagues, including Toshihiro Tanaka and Aritoshi Iida. These partnerships have further enhanced his research and development efforts in the field of cardiac therapeutics.

Conclusion

Masatsugu Hori's contributions to cardiac therapeutics through his innovative patents and collaborations highlight his importance in the medical field. His work continues to pave the way for advancements in the treatment of myocardial infarction and related diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…